Race to the top: how high will treatment response rates in RA reach? We have become used to the 60/40/20% rule for the outcome of ACR 20/50/70 for biologics and targeted synthetic DMARDs. https://t.co/VJplM5GC31 https://t.co/gNsN3wX5tA